Utah Medical Products Files 8-K

TL;DR

UTMD filed an 8-K on Jan 28, 2025, for financial updates.

AI Summary

Utah Medical Products, Inc. filed an 8-K on January 28, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.

Why It Matters

This filing signifies a formal update from Utah Medical Products, Inc. to the SEC regarding its financial status and operational results, which is important for investors and stakeholders to monitor.

Risk Assessment

Risk Level: low — The filing is a standard SEC disclosure and does not inherently present new risks.

Key Players & Entities

• UTAH MEDICAL PRODUCTS, INC. (company) — Registrant
• January 28, 2025 (date) — Date of Report
• 0000706698 (company) — Central Index Key
• 8015661200 (phone_number) — Business Phone

FAQ

Filing Documents

• utmd-20250128.htm (8-K) — 25KB
• utmd_ex99z1.htm (EX-99.1) — 119KB
• 0001096906-25-000095.txt ( ) — 290KB
• utmd-20250128_def.xml (EX-101.DEF) — 2KB
• utmd-20250128_lab.xml (EX-101.LAB) — 20KB
• utmd-20250128_pre.xml (EX-101.PRE) — 13KB
• utmd-20250128.xsd (EX-101.SCH) — 2KB
• utmd-20250128_htm.xml (XML) — 2KB

02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated January 28, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

01—FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Financial information for Utah Medical Prod ucts, Inc. for the three and twelve months ended December 31, 2024 and forward-loo king statements relating to 2024 and beyond as present ed in a press release dated January 28, 2025 . This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: January 28, 2025 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR